Sort
64,565 grants matching “drug discovery”
Optimization and preclinical development of FAAH inhibitors for smoking cessation
$742,050Daniele Piomelli · University Of California-Irvine · DP1 · FY2011 · DA
Optimization and preclinical development of FAAH inhibitors for smoking cessation
$742,050Daniele Piomelli · University Of California-Irvine · DP1 · FY2012 · DA
Optimization and preclinical development of FAAH inhibitors for smoking cessation
$742,050Daniele Piomelli · University Of California-Irvine · DP1 · FY2014 · DA
Studies in the Pathogenesis of Systemic Capillary Leak Syndrome
$742,042Kirk Druey · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
University of Washington Center for Aids Research
$742,010King Kennard Holmes · University Of Washington · P30 · FY2014 · AI
Integrated Platform for the Discovery of Antibacterial
$741,949Suzanne L. Walker · Harvard Medical School · U19 · FY2016 · AI
Bacterial and Molecular Determinants of Mycobacterial Impermeability
$741,927Marcos M. Pires · University Of Virginia · R01 · FY2023 · AI
Dissecting the receptor-mediated infection mechanisms of hantaviruses
$741,829Kartik Chandran · Albert Einstein College Of Medicine · R01 · FY2019 · AI
Ubiquitin-independent targeted protein degradation
$741,798Lizbeth K. Hedstrom · Brandeis University · R01 · FY2020 · GM
Development of selective Cav3 channel blockers for treatment of neuropathic pain
$741,690Xinmin Simon Xie · Afasci, Inc. · R44 · FY2016 · NS
Discovery of long-acting, chemoprotective antimalarial compounds
$741,668Elizabeth A Winzeler · University Of California, San Diego · R01 · FY2020 · AI
Discoveries in ADHD genomics: Help or hype in clinical settings?
$741,614Alysa E Doyle · Massachusetts General Hospital · R01 · FY2020 · MH
Defining the Role of Host Factors in Ebola Virus RNA Synthesis
$741,604Douglas J. Lacount · Washington University · P01 · FY2017 · AI
Automated Compound Storage and Retrieval System
$741,378Joshua A. Bauer · Vanderbilt University · S10 · FY2022 · OD
Development of dual inhibitors targeting the viral main protease and the host cathepsin L as SARS-CoV-2 antivirals
$741,356Jun Wang · Rutgers Biomedical And Health Sciences · R01 · FY2022 · AI
Integrative multi-omics for discovery of molecular pathways associated with diabetic retinopathy
$741,232Dolly Ann Padovani-Claudio · Vanderbilt University Medical Center · R01 · FY2025 · EY
Pharmacogenomics of HIV Therapy
$741,228David W Haas · Vanderbilt University Medical Center · R01 · FY2018 · AI
Pharmacogenomics of HIV Therapy
$741,228David W Haas · Vanderbilt University Medical Center · R01 · FY2019 · AI
Pharmacogenomics of HIV Therapy
$741,228David W Haas · Vanderbilt University Medical Center · R01 · FY2017 · AI
MSHS Translational Science Hub
$741,165Alan J Moskowitz · Icahn School Of Medicine At Mount Sinai · KL2 · FY2015 · TR
Algorithm and genome-wide database of functional siRNAs
$741,109Alex Chenchik · Cellecta, Inc. · R44 · FY2008 · HG
Small molecule Parkin activators to treat Alzheimer's Disease
$741,032Feng Wang · Progenra, Inc. · R44 · FY2017 · AG
Safety and modulation of ABCC9 pathways by nicorandil for the treatment of hippocampal sclerosis of aging
$740,936Gregory A Jicha · University Of Kentucky · R01 · FY2021 · AG
A dual-acting small molecule for the treatment of type 1 diabetes
$740,897Shiyong Wu · Asake Biotechnology, Llc · R42 · FY2024 · DK
Towards in vivo imaging with benchtop x-ray fluorescence computed tomography
$740,830Sang Hyun Cho · University Of Tx Md Anderson Can Ctr · R01 · FY2018 · EB